-
Ruxolitinib
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Ruxolitinib Myelofibrosis Novartis Hurae 6, 2024 -
Relugolix
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Relugolix mate pukupuku Prostatic Takeda me ASKA Hanuere 24, 2024 -
Rimegepant
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Rimegepant Migraine ānini Biohaven Pepuere 22, 2031 -
Relugolix 737789-87-6
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Ribociclib CAS: 737789-87-6 Atineoplastic Roto-whare -
Ribociclib 1374639-75-4
Ingoa API Tohutohu Kaihanga hou Te Ra Whakamutunga Patent(Te US) Ribociclib 1374639-75-4 HR-pai, HER2-kino Andvance ormetastatic breast Cancers Novartis
Nga rongoāHune.27, 2028 -
Rivaroxaban
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Rivaroxaban Te whakakorikori Roto-whare TDP -
Rosuvastatin konupora
Ingoa API Tohutohu Whakatakotoranga US DMF EU DMF CEP Rosuvastatin konupora Hypercholesterolemia Roto-Whare/CEP 20705 √ CEP2015-240